Recent studies are reporting, however, that 30% of patients discontinue GLP-1 drugs in the first month with significant muscle mass loss
Currently, WAKIX is the only therapy being studied for PWS patients with EDS, which affects approximately 50% of PWS patients
While the program is designed for anyone looking to lose weight, it is important to consult with a medical professional to determine if GLP-1 medication is right for you
Weight Loss NP-supervised tirzepatide programs with monthly check-ins medication and oversight included, not mail-order
The final product to be selected based on improved pharmacokinetics-pharmacodynamics (PK/PD) profiles and decent stability, providing it an advantage over the existing market products
People planning to come off anti-obesity medication should not abruptly stop it but rather de-escalate the dose to see if dose reduction is a viable option to maintain some weight loss, said Dr